Trial · NCT04411472
Outcomes16
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | 28-day All-cause Mortality: Main Trial Population | 28 days | Main Trial modified intent-to-treat Population | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | 28-day All-cause Mortality: Moderate Chronic Kidney Disease Population | 28 days | Moderate Chronic Kidney Disease modified intent-to-treat Population | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | 28-day All-cause Mortality: COVID-19 Population | 28 days | COVID-19 modified intent-to-treat Population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Major Adverse Kidney Events 90: Main Trial Population | 90 Days | Main Trial modified intent-to-treat Population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Major Adverse Kidney Events 90: Moderate Chronic Kidney Disease Population | 90 Days | Moderate Chronic Kidney Disease modified intent-to-treat Population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Major Adverse Kidney Events 90: COVID-19 Population | 90 Days | COVID-19 modified intent-to-treat Population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Major Adverse Kidney Events Through Day 90: Combined Population | 90 Days | Combined population: From the 650 patients in the mITT population (321 Placebo and 329 recAP), 649 were analysed in the combined population (1 participant randomized and treated with placebo has been excluded as no efficacy data were available). In the combined population participants were analyzed as treated, resulting in 319 Placebo and 330 recAP participants (2 participants randomized to Placebo were treated with recAP, 1 participant randomized to recAP was treated with placebo). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Days Alive and Free of Organ Support Through Day 28: Main Trial Population | 28 days | Main Trial modified intent-to-treat Population | days | MEAN |
| SECONDARY | Days Alive and Free of Organ Support Through Day 28: Moderate Chronic Kidney Disease Population | 28 days | Moderate Chronic Kidney Disease modified intent-to-treat Population | days | MEAN |
| SECONDARY | Days Alive and Free of Organ Support Through Day 28: COVID-19 Population | 28 days | COVID-19 modified intent-to-treat Population | days | MEAN |
| SECONDARY | Days Alive and Out of the ICU Through Day 28: Main Trial Population | 28 days | Main Trial modified intent-to-treat Population | Days | MEAN |
| SECONDARY | Days Alive and Out of the ICU Through Day 28: Moderate Chronic Kidney Disease Population | 28 days | Moderate Chronic Kidney Disease modified intent-to-treat Population | Days | MEAN |
| SECONDARY | Days Alive and Out of the ICU Through Day 28: COVID-19 Population | 28 days | COVID-19 modified intent-to-treat Population | Days | MEAN |
| SECONDARY | 90-day All Cause Mortality: Main Trial Population | 90 days | Main Trial modified intent-to-treat Population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | 90-day All Cause Mortality: Moderate Chronic Kidney Disease Population | 90 days | Moderate Chronic Kidney Disease modified intent-to-treat Population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | 90-day All Cause Mortality: COVID-19 Population | 90 days | COVID-19 modified intent-to-treat Population | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04411472/outcomes